Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,657
Closed -$401K 94
2022
Q1
$401K Sell
1,657
-23
-1% -$5.29K 0.23% 83
2021
Q4
$378K Buy
1,680
+88
+6% +$18.6K 0.2% 84
2021
Q3
$339K Buy
+1,592
New +$366K 0.2% 83
2020
Q3
Sell
-4,750
Closed -$1.12M 81
2020
Q2
$1.12M Sell
4,750
-659
-12% -$150K 0.97% 24
2020
Q1
$1.2M Buy
+5,409
New +$1.18M 1.08% 21
2019
Q4
Sell
-1,072
Closed -$218K 88
2019
Q3
$218K Buy
+1,072
New +$206K 0.18% 89
2019
Q1
Sell
-1,047
Closed -$204K 93
2018
Q4
$204K Hold
1,047
0.19% 74
2018
Q3
$217K Buy
+1,047
New +$206K 0.17% 79
2016
Q2
Sell
-1,047
Closed -$157K 96
2016
Q1
$157K Buy
+1,047
New +$156K 0.14% 80
2015
Q4
Sell
-1,327
Closed -$184K 82
2015
Q3
$184K Hold
1,327
0.17% 72
2015
Q2
$204K Hold
1,327
0.19% 69
2015
Q1
$212K Hold
1,327
0.21% 73
2014
Q4
$211K Buy
+1,327
New +$207K 0.2% 76

Other funds holding AMGN

Donald L. Hagan LLC's AMGN Position: Q2 2022 in Review

Donald L. Hagan LLC sold out of Amgen (AMGN) in Q2 2022, closing a stake of 1,657 shares — an estimated $401K sold.

Donald L. Hagan LLC first reported a position in AMGN in Q4 2014 and held it in 13 quarters. The position peaked at $1.2M in Q1 2020. 2,352 funds tracked by Wall St. Rank hold AMGN as of Q2 2022.

  • Donald L. Hagan LLC reported no remaining Amgen position as of Q2 2022 after selling out during the quarter.
  • Donald L. Hagan LLC sold 1,657 Amgen shares in Q2 2022, an estimated $401K.
  • Donald L. Hagan LLC first reported a position in Amgen in Q4 2014 and held it in 13 quarters.
  • Donald L. Hagan LLC's Amgen position peaked at $1.2M in Q1 2020.
  • 2,352 funds tracked by Wall St. Rank held Amgen as of Q2 2022.

Based on Donald L. Hagan LLC's 13F filing for Q2 2022, filed 20 Jul 2022.